WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies

M Etemadifar; A Aghababaee; N Sedaghat; M Rayani; H Nouri; A Abhari; M Salari; N Majdinasab; M Ghiasian; A Bayati; S M Nabavi; A Mansouri

doi:10.1016/j.neurol.2020.08.001

WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies

Rev Neurol (Paris). 2020 Sep 15:S0035-3787(20)30660-3. doi: 10.1016/j.neurol.2020.08.001. Online ahead of print.

Authors

M Etemadifar¹, A Aghababaee², N Sedaghat³, M Rayani², H Nouri², A Abhari², M Salari⁴, N Majdinasab⁵, M Ghiasian⁶, A Bayati⁷, S M Nabavi⁸, A Mansouri⁹

Affiliations

¹ Department of neurosurgery, Isfahan university of medical sciences, Isfahan, Iran; Alzahra research institute, Isfahan university of medical sciences, Isfahan, Iran.
² Alzahra research institute, Isfahan university of medical sciences, Isfahan, Iran.
³ Alzahra research institute, Isfahan university of medical sciences, Isfahan, Iran. Electronic address: nahad.sedaghat@gmail.com.
⁴ Department of neurological diseases, Shaid Beheshti university of medical sciences, Tehran, Iran.
⁵ Department of neurology, Ahvaz Jundishapur university of medical sciences, Ahvaz, Iran.
⁶ Department of neurology, Hamadan university of medical sciences, Hamadan, Iran.
⁷ Shahrekord university of medical sciences, Shahrekord, Iran.
⁸ Department of neurology and neuroregenerative, Royan institute, Tehran, Iran.
⁹ Hypertension research center, cardiovascular research institute, Isfahan university of medical sciences, Isfahan, Iran.

Abstract

This article has been withdrawn at the request of the authors and editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/policies/article-withdrawal.

Publication types

Retraction of Publication